MoonLake Immunotherapeutics Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 11/14/2025 | 19.75 M | $141.62 M | 0.00% | 31.21% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 2.00 M | $14.34 M | -51.81% | 3.16% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 1.99 M | $14.30 M | -76.52% | 3.15% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 1.70 M | $12.18 M | 301.55% | 2.69% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 1.50 M | $10.76 M | 100.00% | 2.37% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 965.41 K | $6.92 M | 100.00% | 1.53% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 822.96 K | $5.90 M | -68.51% | 1.30% |
| JANE STREET GROUP, LLC | 11/14/2025 | 812.70 K | $5.83 M | 982.16% | 1.28% |
| FMR LLC | 11/13/2025 | 726.93 K | $5.21 M | -87.31% | 1.15% |
| NUVEEN, LLC | 11/12/2025 | 635.70 K | $4.56 M | -19.69% | 1.00% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 612.20 K | $4.39 M | 547.83% | 0.97% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 551.50 K | $3.95 M | 320.99% | 0.87% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 454.27 K | $3.26 M | 100.00% | 0.72% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 450.00 K | $3.23 M | 131.36% | 0.71% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 435.84 K | $3.12 M | 100.00% | 0.69% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 395.20 K | $2.83 M | 33.65% | 0.62% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 362.87 K | $2.60 M | -71.55% | 0.57% |
| MARSHALL WACE, LLP | 11/13/2025 | 321.11 K | $2.30 M | -39.32% | 0.51% |
| TORONTO DOMINION BANK | 11/14/2025 | 316.00 K | $2.27 M | 100.00% | 0.50% |
| CITADEL ADVISORS LLC | 11/14/2025 | 303.20 K | $2.17 M | 1,039.85% | 0.48% |
| VERITION FUND MANAGEMENT LLC | 11/14/2025 | 272.77 K | $1.96 M | 1,059.38% | 0.43% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 263.80 K | $1.89 M | 272.07% | 0.42% |
| FIRST TURN MANAGEMENT, LLC | 11/14/2025 | 262.64 K | $1.88 M | 100.00% | 0.42% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 258.78 K | $1.86 M | 100.00% | 0.41% |
| MORGAN STANLEY | 11/14/2025 | 256.66 K | $1.84 M | 493.57% | 0.41% |
| BOXER CAPITAL MANAGEMENT, LLC | 11/14/2025 | 250.00 K | $1.79 M | 100.00% | 0.40% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 249.80 K | $1.79 M | 9.23% | 0.39% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 244.00 K | $1.75 M | 756.14% | 0.39% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2025 | 207.00 K | $1.48 M | 360.00% | 0.33% |
| CITADEL ADVISORS LLC | 11/14/2025 | 195.60 K | $1.40 M | 934.92% | 0.31% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2025 | 195.49 K | $1.22 M | 908.20% | 0.31% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 194.74 K | $1.40 M | 100.00% | 0.31% |
| EXOME ASSET MANAGEMENT LLC | 11/14/2025 | 178.08 K | $1.28 M | 100.00% | 0.28% |
| JPMORGAN CHASE & CO | 11/26/2025 | 174.16 K | $1.25 M | 342.07% | 0.28% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 151.50 K | $1.09 M | 341.50% | 0.24% |
| WALLEYE TRADING LLC | 11/14/2025 | 146.10 K | $1.05 M | 100.00% | 0.23% |
| LMR PARTNERS LLP | 11/14/2025 | 145.20 K | $1.04 M | 100.00% | 0.23% |
| HRT FINANCIAL LP | 11/14/2025 | 143.28 K | $1.03 M | 100.00% | 0.23% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/13/2025 | 135.50 K | $971.51 K | 376.65% | 0.21% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/16/2025 | 134.84 K | $966.77 K | -5.26% | 0.21% |
| CANDRIAM S.C.A. | 11/06/2025 | 133.64 K | $958.21 K | -7.72% | 0.21% |
| CATALIO CAPITAL MANAGEMENT, LP | 11/14/2025 | 133.13 K | $954.55 K | -18.12% | 0.21% |
| CENTIVA CAPITAL, LP | 11/14/2025 | 132.90 K | $952.89 K | 100.00% | 0.21% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 131.99 K | $946.38 K | -10.65% | 0.21% |
| BLACKROCK, INC. | 11/12/2025 | 125.38 K | $898.98 K | -61.70% | 0.20% |
| VANGUARD GROUP INC | 11/07/2025 | 120.24 K | $862.14 K | -0.52% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 108.10 K | $775.08 K | 31.19% | 0.17% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 106.61 K | $764.39 K | -42.73% | 0.17% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 11/14/2025 | 100.00 K | $717.00 K | 100.00% | 0.16% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 92.30 K | $661.79 K | 100.00% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
MoonLake Immunotherapeutics institutional Ownership - FAQ's
During the previous two years, 196 institutional investors and hedge funds held shares of MoonLake Immunotherapeutics. The most heavily invested institutionals were:
BVF INC/IL: 19.75 M
Avoro Capital Advisors LLC: 2 M
Cormorant Asset Management, LP: 1.99 M
BALYASNY ASSET MANAGEMENT L.P.: 1.7 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 1.5 M
Schonfeld Strategic Advisors LLC: 965,405
59.18% of MoonLake Immunotherapeutics stock is owned by institutional investors.
Institutional investors have bought a total of 39.66 M shares in the last 24 months. This purchase volume represents approximately $530.30 M in transactions.